Deborah Darnley-Fisch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Deborah Darnley-Fisch has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Michele Heisler
3 shared publications- Paula Anne Newman-Casey
Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor
3 shared publications Leslie M. Niziol
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Michigan, Ann Arbor, Michigan
2 shared publicationsPaul P. Lee
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Michigan, Ann Arbor, Michigan
2 shared publicationsAldo Fantin
Department of Ophthalmology, Henry Ford Hospital, 2799 W. Grand Boulevard, Detroit, MI 48202, USA
1 shared publicationAngela R. Elam
Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Elsevier in Ophthalmology Glaucoma
Learning How to Implement Glaucoma Coaching in Academic Medical Centers from a Successful Clinical Trial Using Implementation Science
- 13 October 2026
- Published by Elsevier in Ophthalmology Glaucoma
Open AccessLearning How to Implement Glaucoma Coaching in Academic Medical Centers from a Successful Clinical Trial Using Implementation Science
- 8 August 2022
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 6 (1) , 23-28
Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program
- 8 August 2022
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 6 (1) , 23-28
Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program
- 30 June 2021
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 5 (1) , 47-57
Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program
- 30 June 2021
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 5 (1) , 47-57
Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program
- Open Access
- 21 August 2014
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2014, 1-3
First Reported Case of Proliferative Retinopathy in Hemoglobin SE Disease
We report the first case of proliferative sickle cell retinopathy in a patient with hemoglobin SE (Hb SE) disease. Only a few dozen cases of Hb SE disease have been reported previously, and none had evidence of proliferative retinopathy. A 56-year-old African American man presented to our clinic for routine examination and was found to have sea-fan peripheral neovascularization bilaterally without maculopathy. Hemoglobin analysis revealed Hb SE heterozygosity. Sector laser photocoagulation to areas of nonperfusion in both eyes resulted in regression of the peripheral neovascularization over a period of 6 months. Although Hb SE disease is rare, the incidence of Hb SE disease is postulated to rise in the future. Awareness of its potential ocular complications is needed to appropriately refer these patients for screening.
- 21 August 2014
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2014, 1-3
Open AccessFirst Reported Case of Proliferative Retinopathy in Hemoglobin SE Disease
We report the first case of proliferative sickle cell retinopathy in a patient with hemoglobin SE (Hb SE) disease. Only a few dozen cases of Hb SE disease have been reported previously, and none had evidence of proliferative retinopathy. A 56-year-old African American man presented to our clinic for routine examination and was found to have sea-fan peripheral neovascularization bilaterally without maculopathy. Hemoglobin analysis revealed Hb SE heterozygosity. Sector laser photocoagulation to areas of nonperfusion in both eyes resulted in regression of the peripheral neovascularization over a period of 6 months. Although Hb SE disease is rare, the incidence of Hb SE disease is postulated to rise in the future. Awareness of its potential ocular complications is needed to appropriately refer these patients for screening.